Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (6,981) Arrow Down
Filter Results: (6,981) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (6,981)
    • People  (27)
    • News  (2,580)
    • Research  (3,460)
    • Events  (14)
    • Multimedia  (224)
  • Faculty Publications  (2,235)

Show Results For

  • All HBS Web  (6,981)
    • People  (27)
    • News  (2,580)
    • Research  (3,460)
    • Events  (14)
    • Multimedia  (224)
  • Faculty Publications  (2,235)
← Page 128 of 6,981 Results →
  • March 2021 (Revised January 2023)
  • Case

The Trouble with TCE

By: Vincent Pons, Rafael Di Tella and Galit Goldstein
Trichloroethylene, or TCE, was a chemical used by tens of thousands of businesses in the United States. It was an affordable tool for many. Yet, TCE had been associated with important health risks, including cancer and autoimmune disease. TCE potentially posed other... View Details
Keywords: Trichloroethylene; Toxicity; Lobbying; Chemicals; Health Disorders; Governing Rules, Regulations, and Reforms; Policy; Ethics; Business and Government Relations; Chemical Industry; United States
Citation
Educators
Purchase
Related
Pons, Vincent, Rafael Di Tella, and Galit Goldstein. "The Trouble with TCE." Harvard Business School Case 721-031, March 2021. (Revised January 2023.)
  • 24 Jun 2021
  • Blog Post

Celebrating the Past, Crafting the Future Part 2: The First HBS/HKS Class

The first MBA/MPP and MBA/MPA-ID joint degree programs are 10 years old! 89% of HBS | HKS joint degree alumni have told us that they worked in a role allowing usage of both degrees. Learn more about a few members from the Class of 2011... View Details
  • August 2006 (Revised September 2007)
  • Supplement

Istituto Clinico Humanitas (C): Pronto Soccorso

By: Richard M.J. Bohmer
Follows on from the cases Istituto Clinico Humanitas (A) and (B). Describes the design and running of the new Humanitas Emergency Department. Istituto Clinico Humanitas has developed a very efficient operating system for dealing with elective (largely surgical)... View Details
Keywords: Health Care and Treatment; Organizational Change and Adaptation; Service Operations; Service Delivery; Customer Focus and Relationships; Health Industry; Italy
Citation
Purchase
Related
Bohmer, Richard M.J. "Istituto Clinico Humanitas (C): Pronto Soccorso." Harvard Business School Supplement 607-022, August 2006. (Revised September 2007.)
  • February 1992 (Revised September 2003)
  • Case

Beech-Nut Nutrition Corporation (A-1)

By: Lynn S. Paine
The CEO of Beech-Nut Nutrition Corp. must decide what to do when he receives information that the company's supply of apple juice concentrate may be adulterated. The concentrate is used in many of the company's juice products. It appears that others in the company may... View Details
Keywords: Quality; Law; Ethics; Nutrition; Management Teams; Decisions; Business or Company Management; Communication; Governance Compliance; Information Management; Corporate Finance; Food and Beverage Industry; United States
Citation
Educators
Purchase
Related
Paine, Lynn S. "Beech-Nut Nutrition Corporation (A-1)." Harvard Business School Case 392-084, February 1992. (Revised September 2003.)
  • 31 Jan 2014
  • Working Paper Summaries

The Diseconomies of Queue Pooling: An Empirical Investigation of Emergency Department Length of Stay

Keywords: by Hummy Song, Anita L. Tucker & Karen L. Murrell; Health
  • 09 Nov 2022
  • Blog Post

Building Community: Meet the HBS Latino Student Organization Leadership

three of us represent Mexico, Dominican Republic, and Bolivia; hail from Los Angeles, New York, and La Paz; and worked in tech, finance, and startups before business school. We all bring excitement, passion y sabor to LASO’s leadership.... View Details

    Paul W. Marshall

    MBA Class of 1960 Professor of Management, Paul W. Marshall, is affiliated with the Entrepreneurial Management Unit and teaches The Entrepreneurial Manager in the Turnaround Environment. This Elective Curriculum course focuses on the role of... View Details

    Keywords: aerospace; banking; brokerage; computer; consulting; defense; management consulting; manufacturing; metals; professional services; retail financial services; retailing; steel
    • July 2018
    • Case

    Ce Soir-Là, Ils n'Arrivent Plus Un par Un, Mais par Vagues: Coping with the Surge of Trauma Patients at L'Hôpital Universitaire La Pitié Salpêtrière—Friday, November 13, 2015

    By: Herman B. "Dutch" Leonard, Emilie Billaud and Arnold M. Howitt
    On November 13, 2015, Dr. Marie Borel, Dr. Emmanuelle Dolla, Dr. Frédéric Le Saché, and Professor Mathieu Raux were the doctors in charge of the trauma center at L’Hôpital de la Pitié Salpêtrière in Paris, where dozens of wounded and dying patients, most with severe... View Details
    Keywords: Health Care and Treatment; Crisis Management; Performance Capacity; Decision Making; Leadership; Health Industry; Europe; France; Paris
    Citation
    Educators
    Purchase
    Related
    Leonard, Herman B. "Dutch", Emilie Billaud, and Arnold M. Howitt. "Ce Soir-Là, Ils n'Arrivent Plus Un par Un, Mais par Vagues: Coping with the Surge of Trauma Patients at L'Hôpital Universitaire La Pitié Salpêtrière—Friday, November 13, 2015." Harvard Business School Case 319-032, July 2018.
    • September 2017 (Revised July 2023)
    • Case

    Adaptive Platform Trials: The Clinical Trial of the Future?

    By: Ariel D. Stern and Sarah Mehta
    In July 2017, Dr. Brian M. Alexander, president and CEO of the AGILE Research Foundation, was preparing to launch a new type of clinical trial—an adaptive platform trial—to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer.... View Details
    Keywords: Clinical Trials; Cancer; Adaptive Platform Trials; Platform Trials; Adaptive Trials; Glioblastoma; Health; Health Care and Treatment; Health Testing and Trials; Business Strategy; Innovation Strategy; Health Industry; United States
    Citation
    Educators
    Purchase
    Related
    Stern, Ariel D., and Sarah Mehta. "Adaptive Platform Trials: The Clinical Trial of the Future?" Harvard Business School Case 618-025, September 2017. (Revised July 2023.)
    • Program

    The Women's Leadership Forum

    living group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety Protocols Admissions Criteria and Process We admit candidates to specific sessions on a rolling, space-available basis,... View Details
    • Program

    Senior Executive Leadership Program—India

    carefully designed to facilitate your growth. Your learning will take place on your own, in your small learning group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety Protocols Read... View Details
    • Program

    Investment Management Workshop

    facilitate your growth. Your learning will take place on your own, in your living group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety Protocols Admissions Criteria and Process We... View Details
    • March 2014 (Revised November 2020)
    • Case

    The Novartis Malaria Initiative

    By: Michael Chu, Vincent Marie Dessain and Emilie Billaud
    The Novartis Malaria Initiative was designed, as a result of a precedent–setting agreement with the World Health Organization in 2001, to provide a breakthrough treatment for malaria—"at no profit"—for public health systems. What had begun as an exemplary act of... View Details
    Keywords: Health Care and Treatment; Product Marketing; Corporate Social Responsibility and Impact; Social Enterprise; Pharmaceutical Industry; Switzerland; Africa; Nigeria
    Citation
    Educators
    Purchase
    Related
    Chu, Michael, Vincent Marie Dessain, and Emilie Billaud. "The Novartis Malaria Initiative." Harvard Business School Case 314-103, March 2014. (Revised November 2020.)
    • June 5, 2023
    • Article

    How to Tap the Full Potential of Telemedicine

    By: Mitchell Tang, Louise Short, Ryan June, Matthew Dowling and Ateev Mehrotra
    Telemedicine visits in the United States have fallen sharply since April 2020, but the end of the pandemic should not spell the end of telemedicine. It can play a valuable role in the delivery of health care. The key to tapping its potential is to bring many elements... View Details
    Keywords: Health Care and Treatment; Technological Innovation
    Citation
    Register to Read
    Related
    Tang, Mitchell, Louise Short, Ryan June, Matthew Dowling, and Ateev Mehrotra. "How to Tap the Full Potential of Telemedicine." Harvard Business Review (website) (June 5, 2023).
    • 02 May 2017
    • First Look

    First Look at New Research: May 2, 2017

    April 14, 2017 Harvard Business Review Companies Like United Need to Cultivate Good Judgment, and Free Their Employees to Use It By: Deighton, John A. Abstract—United Airlines has pledged to improve its training programs and empower its... View Details
    Keywords: Carmen Nobel
    • 12 Jun 2012
    • First Look

    First Look: June 12

    customer, there is no value. Instead of using pricing in a way that turns customers into adversaries, companies can use it to enlarge the pie. That means viewing customers as partners in value creation-a... View Details
    Keywords: Sean Silverthorne
    • 2021
    • Working Paper

    Who Do We Invent for? Patents by Women Focus More on Women's Health, but Few Women Get to Invent

    By: Rembrand Koning, Sampsa Samila and John-Paul Ferguson
    Has the increase in female medical researchers led to more medical advances for women? In this paper, we investigate if the gender of inventors shapes their types of inventions. Using data on the universe of U.S. biomedical patents, we find that patents with women... View Details
    Keywords: Innovation; Biomedical Research; Innovation and Invention; Diversity; Gender; Research; Health; United States
    Citation
    Read Now
    Related
    Koning, Rembrand, Sampsa Samila, and John-Paul Ferguson. "Who Do We Invent for? Patents by Women Focus More on Women's Health, but Few Women Get to Invent." Working Paper. (Harvard Business School Working Paper, No. 19-124, June 2019; SSRN Working Paper Series, No. 3401889, June 2019.)

      Michael Lingzhi Li

      Keywords: health care; health care
      • 25 Feb 2019
      • News

      Impact investing: a new way to fund cures for cancer

      • 13 Aug 2009
      • Working Paper Summaries

      In Favor of Clear Thinking: Incorporating Moral Rules into a Wise Cost-Benefit Analysis

      Keywords: by Max H. Bazerman & Joshua D. Greene
      • ←
      • 128
      • 129
      • …
      • 349
      • 350
      • →
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Accessibility
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College.